Stocktoria
CRYO CELL INTERNATIONAL INC CCEL
NYSE American · XASE · stock · Services-Misc Health & Allied Services, NEC · website · IPO 1994-04-04
CRYO CELL INTERNATIONAL INC statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
CRYO CELL INTERNATIONAL INC trades at about 66.4× earnings — above its 10-year norm (10-year range 3.9×–148.2×, median 32.2×).
3.9×
148.2×
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 1.5% | 10.9% | -39.3% | 13.3% | 13.9% | 24.6% | 15.9% | 17.8% | 19.7% | 1.9% |
| Net margin | -7.7% | 1.3% | -30.4% | 9.1% | 7.2% | 11.6% | 7.2% | -2.9% | 9.1% | -5.7% |
| FCF margin | 16.6% | 11.3% | 6.6% | -11.9% | 21.1% | 26.9% | 17.7% | 16.7% | 22.1% | 20.1% |
| Return on assets | -3.9% | 0.6% | -14.7% | 4.3% | 3.4% | 7.8% | 5.3% | -2.0% | 9.7% | -6.8% |
| Return on equity | 13.1% | -3.0% | 86.3% | -181.8% | 49.8% | -136.0% | -32.9% | 9.6% | -18.5% | 8.6% |
| Debt / equity | -0.45× | -0.64× | -0.78× | -5.73× | 0.45× | -2.23× | -1.29× | -1.45× | -0.58× | -0.64× |
| Current ratio | 0.59 | 0.58 | 0.45 | 0.49 | 0.75 | 1.13 | 1.00 | 0.96 | 0.91 | 0.69 |
Source: SEC EDGAR filings · CIK 0000862692 · as of 2025-11-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.